BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 19, 2025
Home » Authors » John Brosky

Articles by John Brosky

France turns serious as it relaunchs e-health plan

May 21, 2010
By John Brosky
PARIS – In an unusual show of solidarity, the two agencies charged with implementing France's ambitious programs for e-health held a joint press conference during the Health Information Technology exposition held here last week to announce the signing of a collaborative agreement spelling out their roles and responsibilities. (Medical Device Daily)
Read More

Siemens, Olympus develop guided pill camera for endoscopy

May 3, 2010
By John Brosky

E-health chugging toward tipping point in Europe

April 21, 2010
By John Brosky

France set to launch patient health record by end of 2010

April 20, 2010
By John Brosky

Europe readies large-scale, cross-border exchange of EHRs

April 19, 2010
By John Brosky

Report from Europe: GE's spectral X-ray targets lines at MRI for breast exams

April 12, 2010
By John Brosky

ESR says teleradiology is a medical act, not merely sending images

April 1, 2010
By John Brosky

Philips, GE face-off in HIFU-MRI, may grow long-stalled market

March 11, 2010
By John Brosky
VIENNA, Austria — Don't say HIFU, please just say it is non-invasive treatment of uterine fibroids. Like any industry, radiology is an alphabet soup of acronyms with major imaging modalities promoted as MRI, US and CT, with contrast enhancement adding to the mix for marketing materials touting CE-CT or CE-US, and even emerging metabolic imaging crossing over from nuclear medicine quickly creating SPECT or PET-MRI. (Medical Device Daily)
Read More

Philips challenges 'conventional' PET-CT with novel MR technology

March 10, 2010
By John Brosky
VIENNA, Austria — If doctors liked PET-CT, they are going to love PET-MRI. And despite its high cost, doctors like PET-CT a lot, valuing the new insights into the biology of specific tumors offered by this technology that fuses metabolic processes shown by PET images layered over the anatomical references provided by with CT. (Medical Device Daily)
Read More

Agfa revives its product portfolio after slump, rumors of unit sale

March 9, 2010
By John Brosky
VIENNA, Austria — What a difference a year makes. At last year's European Congress of Radiology, Agfa Healthcare (Mortsel, Belgium) was on the ropes and the buzz among sales reps and executives in the corridors was that this division, which accounts for 40% of sales for the larger Agfa-Gevaert Group would be sold. (Medical Device Daily)
Read More
Previous 1 2 … 55 56 57 58 59 60 61 62 63 … 101 102 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 18, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 18, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing